2018 Call for Letters of Intent NOW OPEN.
LOI due on 7 September 2018.
The THRIVE program seeks to chart new futures for cancer patients and survivors by
Making Patient Quality of Life an Active Research Priority.
The biomedical field has made tremendous strides in turning many cancers into survivable diseases. However,
- In the years and decades following treatment, many survivors have a significantly higher incidence of severe chronic illness – often an unintended consequence of the drugs and therapies that saved their lives.
- Effects can include cardiac dysfunction or failure, pulmonary problems, neurological issues, liver toxicity, and endocrine disorders among others.
THRIVE fills a critical gap in funding for foundational research in support of future protective therapies, mitigation strategies and a next generation of drugs that will enhance the ability for cancer survivors to THRIVE.
Join us in making a difference.
HESI is a non-profit, 501c3 charitable organization that convenes leading scientists from the public and private sector to identify emerging health challenges and solutions, translates science from research to application, and enhances the protection of human and the environment health worldwide. www.hesiglobal.org